Prostate cancer metastasis-driving genes: hurdles and potential approaches in their identification

Stephenson, 2007, J Clin Oncol, Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy, 2035

Jemal, 2010, CA Cancer J Clin, Cancer statistics, 2010, 277

Osanto, 2012, Ther Adv Urol, Emerging novel therapies for advanced prostate cancer, 3

Mukherji, 2012, Drugs, Management of metastatic castration-resistant prostate cancer: recent advances, 1011

Talmadge, 2010, Cancer Res, AACR centennial series: the biology of cancer metastasis: historical perspective, 5649

Liang, 2012, J Biol Chem, Transcriptional network analysis identifies BACH1 as a master regulator of breast cancer bone metastasis, 33533

Tung, 2011, Prostate, Use of irinotecan for treatment of small cell carcinoma of the prostate, 675

Collins, 2012, Mol Cancer Ther, Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor target, 775

Wang, 2005, Lab Invest, An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line, 1392

Watahiki, 2011, PLoS One, MicroRNAs associated with metastatic prostate cancer, e24950

Taylor, 2010, Cancer Cell, Integrative genomic profiling of human prostate cancer, 11

Cerami, 2012, Cancer Discov, The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data, 401

Cheung, 2004, Cancer Res, Protein profiling of microdissected prostate tissue links growth differentiation factor 15 to prostate carcinogenesis, 5929

Lin, 2008, Cancer Res, ASAP1, a gene at 8q24, is associated with prostate cancer metastasis, 4352

Chen Z, Ehsanian R, Waes CV. Nuclear transcription factors and signaling pathways in oral cancer metastasis. In: Myers J, editor. Oral Cancer Metastasis. New York: Springer; 2009. p. 197-229.

Nebert, 2002, Toxicology, Transcription factors and cancer: an overview, 131

Voskoglou-Nomikos, 2003, Clin Cancer Res, Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models, 4227

Bott, 2005, Surg Oncol, Molecular changes in prostatic cancer, 91

Sharpless, 2006, Nat Rev Drug Discov, The mighty mouse: genetically engineered mouse models in cancer drug development, 741

Mazzoccoli, 2011, Chronobiol Int, Clock gene expression levels and relationship with clinical and pathological features in colorectal cancer patients, 841

Hsu, 2012, Tumour Biol, Altered expression of circadian clock genes in head and neck squamous cell carcinoma, 149

Fu, 2012, Mol Carcinog, Genetic and epigenetic associations of circadian gene TIMELESS and breast cancer risk, 923

Starkova, 2011, Haematologica, Up-regulation of homeodomain genes, DLX1 and DLX2, by FLT3 signaling, 820

Chiba, 2003, Proc Natl Acad Sci U S A, Homeoprotein DLX-1 interacts with Smad4 and blocks a signaling pathway from activin A in hematopoietic cells, 15577

Kramer, 2013, Mutat Res, In vitro cell migration and invasion assays, 10

Junttila, 2013, Nature, Influence of tumour micro-environment heterogeneity on therapeutic response, 346

Chan SS, Kyba M. What is a Master Regulator? J Stem Cell Res Ther. 2013 May 4;3. pii: 114.

Heinz, 2013, Nature, Effect of natural genetic variation on enhancer selection and function, 487−92

Carro, 2010, Nature, The transcriptional network for mesenchymal transformation of brain tumours, 318

Pe′er, 2011, Cell, Principles and strategies for developing network models in cancer, 864

Margolin, 2006, BMC Bioinformatics, ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context, S7

Wang, 2009, Nat Biotechnol, Genome-wide identification of post-translational modulators of transcription factor activity in human B cells, 829

Koutsogiannouli, 2013, Cancer Med, Complexity in cancer biology: is systems biology the answer?, 164

Chiang, 2014, Oncotarget, GATA2 as a potential metastasis-driving genes in prostate cancer, 451

Wu, 2012, Nature, Clonal selection drives genetic divergence of metastatic medulloblastoma, 529